For the complete report, get in touch with us at: info@netscribes.com Abstract: Netscribes latest market research report titled HbA1c Testing Market in India 2014 states that with the increasing incidence of diabetes in the country, the demand for HbA1c testing is rising. India is characterized by the presence of a large diabetic population. The countrys status as the diabetes capital of the world has made the need for diabetes prevention and screening very important. Hence, tests for measuring the blood glucose levels are facing high demand within the country. Naturally, HbA1c testing in the country is also benefiting from this trend. The ability to measure ones blood glucose levels over a period of 3 months has made it a test favored by many diabetics as well as people who believe they are at high risk of developing diabetes. The market for HbA1c testing has been growing steadily and with the awareness level regarding it increasing rapidly, the market is set to boom in the next few years. Although the test is considered to be very useful for diabetes screening as well as for monitoring the diabetes status of a patient, its much higher cost compared to a simple blood sugar level test can act as a hindrance to its greater acceptance. However, the need to go for HbA1c tests only 3-4 times a year unlike the blood sugar level test which may have to be done on a monthly basis may work in favor of the former. Moreover, HbA1c tests give a clearer picture of the diabetes status of a patient as it a measurement of the glucose levels over a longer period. Several physicians also prescribe this test to their patients which in turn will increase its demand and thereby drive growth in the market. Several large diagnostic chains offer these tests in India. Majority of the patients going for these tests are confirmed diabetics with very few non-diabetics undergoing this test. Most of the patients visiting laboratories for HbA1c tests have been prescribed to go for this test by a physician and very few people opt for the test on their own. However, with increasing awareness among people, this ratio is likely to change and many more people are expected to go for this test independently. Table of Contents:

1. Insert Cover Image using Slide Master View
Do not distort
HbA1c Testing Market – India
September 2014

2. 2
HbA1c TESTING MARKET IN INDIA 2014.PPT
Executive Summary
Market
Drivers & Challenges
Technology Trends
Competitive Landscape
Drivers
Increase in the number of diabetics
 Growing need for diabetes diagnosis
Increasing ageing population
Comprehensive health insurance policies covering diabetics
Challenges
Test results can be influenced
High price of tests
Racial and ethnic variations in HbA1c results
Major Diagnostic Service Providers
Company 1
Company 2
Company 3
Major HbA1c Analyzer and Reagent Manufacturers
Company 4
Company 5
Company 6
Latex Enhanced Immunoassay Method
Enzymatic HbA1c Assay Method
High-Performance Liquid Chromatography Method
India is facing a persistent rise in its diabetic patient population and the number is estimated to grow from ‘u’ mn in 2013 to ‘v’ mn in 2018
HbA1c testing market in India is expected to reach INR ‘h1’ bn in 2018, growing at a CAGR of ‘x1’% from INR ‘a1’ bn in 2012

3. 3
•Macroeconomic Indicators
•Introduction
•Market Overview
Testing
HbA1c
•Drivers & Challenges
•Diabetes Disease Trends
•Technology Trends
•Competitive Landscape
•Strategic Recommendations
•Appendix
HbA1c TESTING MARKET IN INDIA 2014.PPT

4. 4
Macroeconomic Indicators (1/3)
11
12
13
14
15
INR tn
Q4
c4
b4
a4
Q3
c3
b3
a3
Q2
d2
c2
b2
a2
Q1
d1
c1
b1
a1
2010-11 2011-12 2012-13 2013-14
GDP at Factor Cost: Quarterly
Inflation Rate: Monthly
-2
-1
0
1
2
Aug 2013 - Sep 2013
q
p
%
Sep 2013 - Oct 2013 Nov 2013 - Dec 2013
-t
Oct 2013 - Nov 2013
s
Jul 2013 - Aug 2013
r
HbA1c TESTING MARKET IN INDIA 2014.PPT

5. 5
• Healthcare expenditure comprises ~y% of India’s GDP
• Favorable demographics, increase in awareness levels
and better medical care are some factors that are
driving the healthcare sector in India
• Hospitals form the largest segment of overall
healthcare market, followed by pharmaceuticals,
medical devices, health insurance and diagnostics
• Gradual penetration of health insurance is stepping up
affordability of health services through increased
demand for preventive and curative healthcare services
• Superior quality healthcare, coupled with low
treatment costs in comparison to other countries, is
benefitting Indian medical tourism, thereby driving the
Indian healthcare market
• Treatment for major surgeries in India costs
approximately 20% of that in developed countries
0
5
10
15
INR tn
+16.6%
2015e
d
2014e
c
2013e
b
2012
a
2018
h
2017e
g
2016e
f
Healthcare Market Size & Growth
Healthcare Market – Segmentation (2012)
Healthcare Industry Overview
r%
q%
p%
u%
s% t%
Segment 3
Segment 2
Segment 1
Others
Segment 5
Segment 4
N.B.: Diagnostics include both Pathology and Radiology
Healthcare system in India requires a large public outlay due
to the huge population base
HbA1c TESTING MARKET IN INDIA 2014.PPT

6. 6
Diabetes is a major 21st century disease that would affect
nearly one-tenth of the world population by 2030
Diabetes – Global Overview
0
100
200
300
400
500
mn
c
2012
b
2011
a
+2.13%
2020e
k
2019e
j
2018e
i
2017e
h
2016e
g
2015e
f
2014e
d
2013
Global Prevalence of Diabetes
• Diabetes is one of the major health and development challenges that the world is facing today with an estimated
‘w’ mn deaths due to diabetes in 2013
• In addition, about ‘v’ mn people do not have access to the necessary medicines and technologies required to
maintain their health and prevent complications arising out of diabetes
• It is estimated that by 2035, there will be around ‘y’ mn people living with diabetes
•China and India together constitute ~p% of global diabetes prevalence
HbA1c TESTING MARKET IN INDIA 2014.PPT

7. 7
Rising diabetic population of India will ensure steady growth
of HbA1c testing
• HbA1c market in India is expected to reach INR ‘h1’ bn in 2018, growing at a CAGR of ‘x1’% from INR ‘a1’ bn in 2012
• HbA1c tests can be offered exclusively or in packages with other tests by diagnostic service providers
• High-Performance Liquid Chromatography (HPLC) method is currently the most common method adopted for
conducting HbA1c tests in India
• PoCT for HbA1c testing at the household level is not available in the domestic market and hence, the laboratories and
hospitals offering HbA1c tests hold 100% market share
• There is a growing level of awareness among the diabetic patient population of India about HbA1c testing which is
leading them to take the test independently, which in turn, will suitably drive the HbA1c testing market in India
 Approximately 3%-5% of the HbA1c test takers come without doctor’s recommendation
8
6
4
2
0
2015e
d1
2014e
c1
2013
b1
2012
a1
INR bn
+x1%
2018e
h1
2017e
g1
2016e
f1
HbA1c Market Size & Growth HbA1c Tests Conducted Annually
HbA1c – Market Overview
0
5
10
15 h2
2017e
g2
2016e
f2
2015e
d2
2014e
c2
2013
b2
2012
a2
mn
+x2%
2018e
HbA1c TESTING MARKET IN INDIA 2014.PPT

8. 8
Drivers & Challenges – Summary
Drivers
Increase in the number of diabetics
Growing need for diabetes diagnosis
Increasing ageing population
Comprehensive health insurance policies covering diabetics
Challenges
Test results can be influenced
High price of tests
Racial and ethnic variations in HbA1c test results
HbA1c TESTING MARKET IN INDIA 2014.PPT

9. 9
Diabetes Disease Trends– Summary
`
Diabetic Retinopathy
Chronic Kidney Diseases
Cardiovascular Disease
Cataract
Foot Ulcers
Glaucoma
Diabetic Neuropathy
Diabetes Disease Trends
HbA1c TESTING MARKET IN INDIA 2014.PPT

10. 10
Competitive Rivalry
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitutes
Threat of New Entrants
Impact
XX
Impact
XX
Impact
XX
Impact
XX
Impact
XX
Market Competition – Porter’s Five Forces Analysis
HbA1c TESTING MARKET IN INDIA 2014.PPT

11. 11
Key Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3)
Competitive Benchmarking – Diagnostic Service Providers
(1/4)
-20
0
20
40
60
%
SRL Diagnostics Pvt. Ltd.
b3
a3
Dr. Lal Pathlabs Pvt. Ltd.
b2
a2
Apollo Health and Lifestyle Ltd.
-b1
a1
Operating Margin Net Margin
• Company 1 recorded operating margin of a1%, higher than that of Company 2 and Company 3 which recorded
operating margin of a2% and a3% respectively
• Net margin was highest for Company 2 which recorded a net margin of b2%, followed by Company 3 and Company 1.
which recorded net margin of b3% and –b1% respectively
HbA1c TESTING MARKET IN INDIA 2014.PPT

12. 12
Private: Domestic Company – Company 1 (1/5)
Key People
Products and Services
Company Information
Offices and Centres – India
Category
Products/Services
Consultations
Diagnostics
Heath Check
Others
Name
Designation
Person 1
Whole-Time Director
Person 2
Director
Person 3
Director
Person 4
Director
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation
Head Office
HbA1c TESTING MARKET IN INDIA 2014.PPT

13. 13
Name
No. of Shares held
Shareholder 1
Shareholder 2
Shareholder 3
Shareholder 4
Shareholder 5
Shareholder 6
Shareholder 7
Shareholder 8
Total
100%
Category 1
Shareholders of the Company
Ownership Structure
HbA1c TESTING MARKET IN INDIA 2014.PPT
Private: Domestic Company – Company 1 (2/5)

14. 14
Financial Snapshot Key Ratios
Improved Decline
Financial Summary
• Company incurred a net loss of INR XX mn in FY 20XX, as
compared to net profit of INR Y mn in FY 20YY
• It reported total Income of INR XX mn in FY 20XX, registering
an increase of X per cent over FY 20YY
• It earned an operating margin of X.X per cent in FY 20XX an
increase of X.X percentage points over FY 20YY
• The company reported debt to equity ratio of X.XX in FY 20XX,
an increase of X.X per cent over FY 20YY
Total Income Net Profit/Loss
-50
-100
-150
800
600
50
0
400
200
0
INR mn INR mn
2013
-q4
p4
2012
-q3
p3
2011
q2
p2
2010
q1
p1
Particulars
y-o-y change
(2013-12)
2013 2012 2011
Profitability Ratios
Operating Margin
Net Margin
Profit Before Tax Margin
Return on Equity
Return on Capital Employed
Return on Working Capital
Return on Assets
Return on Fixed Assets
Cost Ratios
Operating costs (% of Sales)
Administration costs (% of Sales)
Interest costs (% of Sales)
Liquidity Ratios
Current Ratio
Cash Ratio
Leverage Ratios
Debt to Equity Ratio
Debt to Capital Ratio
Interest Coverage Ratio
Efficiency Ratios
Fixed Asset Turnover
Asset Turnover
Current Asset Turnover
Working Capital Turnover
Capital Employed Turnover
HbA1c TESTING MARKET IN INDIA 2014.PPT
Private: Domestic Company – Company 1
(3/5)

15. 15
Business Highlights
Description
News
Overview
•XX
Diagnostics
•XX
HbA1c
•XX
Future Plans
•XX
HbA1c TESTING MARKET IN INDIA 2014.PPT
Private: Domestic Company – Company 1 (4/5)

16. 16
T
O
W
S
HbA1c TESTING MARKET IN INDIA 2014.PPT
Private: Domestic Company – Company 1 – SWOT Analysis (5/5)

17. 17
Key People
Products and Services
Company Information
Head Office – India
Corporate Address
Tel No.
Fax No.
Website
Year of Incorporation
Ticker Symbol
Stock Exchange
Name
Designation
Person 1
Chairman
Person 2
Managing Director
Person 3
Independent Director
Person 4
Independent Director
Category
Products/Services
Pharmaceutical & Nutritional
Medical Products and Diagnostic Tests
Head Office
HbA1c TESTING MARKET IN INDIA 2014.PPT
Public: Foreign Company – Company 2 (1/4)

18. 18
Key Ratios
Financial Summary
• Company incurred a net loss of INR XX mn in FY 20XX, as compared to net
profit of INR Y mn in FY 20YY
• It reported total Income of INR XX mn in FY 20XX, registering an increase
of X per cent over FY 20YY
• It earned an operating margin of X.X per cent in FY 20XX an increase of X.X
percentage points over FY 20YY
• The company reported debt to equity ratio of X.XX in FY 20XX, an increase
of X.X per cent over FY 20YY
Improved Decline
Financial Snapshot
Financial Summary
Indicators Value (dd/mm/yyyy)
Market Capitalization (INR mn)
Total Enterprise Value (INR mn)
EPS (INR)
PE Ratio (Absolute)
Total Income Net Profit / Loss
0
5,000
10,000
15,000
20,000
0
500
1,000
1,500
2,000
INR mn INR mn
2013
b4
a4
2012
b3
a3
2011
b2
a2
2010
b1
a1
Public: Foreign Company – Company 2
(2/4)
HbA1c TESTING MARKET IN INDIA 2014.PPT
Particulars
y-o-y change
(2013-12)
2013 2012 2011 2010
Profitability Ratios
Operating Margin
Net Margin
Profit Before Tax Margin
Return on Equity
Return on Capital Employed
Return on Working Capital
Return on Assets
Return on Fixed Assets
Cost Ratios
Operating costs (% of Sales)
Administration costs (% of
Sales)
Interest costs (% of Sales)
Liquidity Ratios
Current Ratio
Cash Ratio
Leverage Ratios
Debt to Equity Ratio
Debt to Capital Ratio
Interest Coverage Ratio
Efficiency Ratios
Fixed Asset Turnover
Asset Turnover
Current Asset Turnover
Working Capital Turnover
Capital Employed Turnover

19. 19
Key Business Segments Key Geographic Segments
Business Highlights
Description News
Overview • XX
HbA1c Testing • XX
Future Plans • TXX
100%
50%
0%
2013
100%
Segment 1
100%
50%
0%
2013
100%
Region 1
Region 1 is the only geographic
segment in which the company
operates
Public: Foreign Company – Company 2
(3/4)
The company operates only in
the Segment 1
HbA1c TESTING MARKET IN INDIA 2014.PPT

20. 20
T
O
W
S
HbA1c TESTING MARKET IN INDIA 2014.PPT
Public: Foreign Company – Company 2 – SWOT Analysis (4/4)

21. 21
Thank you for the attention
About Netscribes, Inc.
Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives.
HbA1c Testing Market – India report is part of Research on India’s Healthcare Industry Series.
For any queries or customized research requirements, contact us at:
Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.
Phone: +91 22 4098 7600 E-Mail: info@netscribes.com
HbA1c TESTING MARKET IN INDIA 2014.PPT